--- title: "Tsingke Biotech launches new website today to simplify global biotech R&D and translational services access." description: "On January 20, 2026, Beijing Tsingke Biotech Co., Ltd., a prominent biotechnology firm, revealed the release of its updated worldwide website. The new website is designed to streamline access to the c" type: "news" locale: "en" url: "https://longbridge.com/en/news/273061952.md" published_at: "2026-01-20T09:19:34.000Z" --- # Tsingke Biotech launches new website today to simplify global biotech R&D and translational services access. > On January 20, 2026, Beijing Tsingke Biotech Co., Ltd., a prominent biotechnology firm, revealed the release of its updated worldwide website. The new website is designed to streamline access to the company's wide range of biotech research and development (R&D) as well as translational services. This update comes as the company continues to make significant progress in their field. On January 20, 2026, Beijing Tsingke Biotech Co., Ltd., a prominent biotechnology firm, revealed the release of its updated worldwide website. The new website is designed to streamline access to the company's wide range of biotech research and development (R&D) as well as translational services. This update comes as the company continues to make significant progress in their field. ### Related Stocks - [25213.HK - 甫康生物科技(上海)股份有限公司](https://longbridge.com/en/quote/25213.HK.md) - [25225.HK - 杭州先为达生物科技股份有限公司](https://longbridge.com/en/quote/25225.HK.md) - [26004.HK - 益方生物科技(上海)股份有限公司](https://longbridge.com/en/quote/26004.HK.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | 3.5 亿首付款、总额达 85 亿美元！信达生物与礼来合作布局肿瘤免疫新药研发 | 信达生物与礼来达成突破性合作，将联合开发肿瘤及免疫新药。此次交易预付款 3.5 亿美元，总额最高达 85 亿美元。双方摒弃传统授权，采用从零开始的共同研发模式，标志着中国药企创新力获全球顶尖药企深度认可，开启全球战略协作新篇章。 | [Link](https://longbridge.com/en/news/275269682.md) | | 早盘趋势｜中国生物制药回踩低点，反弹窗口会否开启？ | 中国生物制药（1177.HK）近期股价持续低位震荡整理，日线呈现小幅阴阳交替，整体重心下移。近几个交易日，股价回踩至前低区间附近，成交量持续萎缩，场内增量资金观望情绪浓厚。从技术面看，MACD 指标依旧死叉，绿柱显著，短线多空分歧较大。 基 | [Link](https://longbridge.com/en/news/274497353.md) | | 港股异动速递：中科生物大涨 27.63%，恒月控股涨 20.91%，诺比侃跌 15.90% | 港股近一小时市场概况整体市场呈现出明显的分化态势，资金流向小盘股和题材股，尤其是生物科技和消费品板块表现活跃。中科生物的强势上涨引领了市场情绪，吸引了大量短线资金的关注。与此同时，恒月控股也表现不俗，涨幅超过 20%，显示出市场对其未来发展 | [Link](https://longbridge.com/en/news/275569449.md) | | ZAWYA-PRESSR：沙迦的 EPAA 推出生物多样性保护和自然保护的战略建议 | 沙迦环境与保护区管理局（EPAA）在第 25 届沙迦国际保护论坛后发布了生物多样性保护的战略建议。这些建议重点在于增强区域生物多样性评估能力、管理入侵物种以及改善海洋野生动物应对协议。EPAA 主席艾莎·拉希德·迪马斯强调了基于科学的决策和 | [Link](https://longbridge.com/en/news/275432705.md) | | 美股盘中速递：Moolec Science SA 股价暴涨 111.53%，生物科技突破引发市场热潮！ | Moolec Science SA 涨 111.53%；卡夫亨氏涨 0.68%，成交额达到 19.92 百万美元；亿滋国际涨 0.02%，成交额达到 16.49 百万美元；好时涨 0.30%，成交额达到 9.58 百万美元；通用磨坊跌 0. | [Link](https://longbridge.com/en/news/275915268.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.